2352 Sunitinib as second-line treatment in patients with advanced intrahepatic cholangiocarcinoma: Final results of the SUN-CK phase II trial from GERCOR IRC. (September 2015) - Neuzillet, C.; Seitz, J.F.; Fartoux, L.; Malka, D.; Lledo, G.; Tijeras-Raballand, A.; De Gramont, A.; Ronot, M.; Bouattour, M.; Dreyer, C.; Granier, M.; Benner, S.; et al.